Loomis Sayles Small Cap Growth Portfolio RARE Holdings History
Loomis Sayles Small Cap Growth Portfolio's Ultragenyx Pharmaceutical Inc Holding Summary
As of 2025-03-31, Brighthouse Funds Trust II held 47,659.00 shares of Ultragenyx Pharmaceutical Inc(RARE), totaling $1.73 Mil. This investment constitutes 0.59% of their stock portfolio, and Brighthouse Funds Trust II now holds 0.05% of the outstanding Ultragenyx Pharmaceutical Inc(RARE) stock.
The initial trade took place in 2019Q3. And since then Loomis Sayles Small Cap Growth Portfolio has made 1 purchases of RARE, at an average price of $46.17, for a total of 74,426.00 shares. In addition, there have been 1 sales at an average price of $41.24 for 26,767.00 shares. Based on historical transaction data and RARE's current price of $39.91, Loomis Sayles Small Cap Growth Portfolio's estimated gain on his RARE holdings is $-430,656.07, reflecting a -12.53% gain to date.
Loomis Sayles Small Cap Growth Portfolio RARE ($39.91) Holding Chart
Loomis Sayles Small Cap Growth Portfolio RARE ($39.91) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
